Abstract
Endocrine oncology is a complex area that must determine the site of a neoplastic process and the hormonal dysregulation that ensues. Patients with endocrine tumors often have delayed diagnosis because of the nonspecific and often subtle signs and symptoms. In patients with multiple endocrine neoplasia syndromes, diagnosis and clinicopathologic correlations can be even more challenging. We report a patient with multiple endocrine neoplasia type 1 (MEN-1) and a highly complex clinical story associated with multiple atypical lesions including two pituitary adenomas, a gonadotroph macroadenoma and a corticotroph microadenoma with Crooke’s hyaline change and ectopic production of corticotropin-releasing hormone (CRH) from a thymic endocrine carcinoma. These lesions resulted in a highly complex clinical story, difficult diagnoses and questions about management. This case illustrates a number of clinically relevant challenges, including the diagnosis of pituitary adenomas in MEN-1, the difficulty in diagnosing Cushing’s disease, and the large differential of pituitary pathologies in this disorder, double pituitary adenomas and other decoy lesions in Cushing’s disease, the pathophysiology of Crooke’s hyaline change in the pituitary, and the various causes of Cushing’s syndrome associated with MEN-1.
This is a preview of subscription content, log in via an institution to check access.
References
Sugiura H, Morikawa T, Itoh K, et al. Thymic carcinoid in a patient with multiple endocrine neoplasia type 1: report of a case. Surg Today 31:428–32, 2001.
Verges B, Boureille F, Goudet P, et al. Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study. J Clin Endocrinol Metab 87:457–65, 2002.
Scheithauer BW, Laws ER, Jr., Kovacs K, et al. Pituitary adenomas of the multiple endocrine neoplasia type I syndrome. Sem Diagn Pathol 4:205–11, 1987.
Benito M, Asa SL, LiVolsi VA, West VA, Snyder PJ. Gonadotroph tumor associated with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 90:570–4, 2005.
Asa SL. Tumors of the pituitary gland. Atlas of Tumor Pathology, third series, fascicle 22. Washington, D.C.: Armed Forces Institute of Pathology; 1998.
Katznelson L, Bogan JS, Trob JR, et al. Biochemical assessment of Cushing’s disease in patients with corticotroph macroadenomas. J Clin Endocrinol Metab 83:1619–23, 1998.
Woo YS, Isidori AM, Wat WZ, et al. Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomas. J Clin Endocrinol Metab 90:4963–9, 2005.
Nieman LK, Chrousos GP, Oldfield EH, et al. The ovine corticotropin-releasing hormone stimulation test and the dexamethasone suppression test in the differential diagnosis of Cushing’s syndrome. Ann Inter Med 105:862–7, 1986.
Oldfield EH, Doppman JL, Nieman LK, et al. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing’s syndrome. N Engl J Med 325:897–905, 1991.
Swearingen B, Katznelson L, Miller K, et al. Diagnostic errors after inferior petrosal sinus sampling. J Clin Endocrinol Metab 89:3752–63, 2004.
Booth GL, Redelmeier DA, Grosman H, et al. Improved diagnostic accuracy of inferior petrosal sinus sampling over imaging for localizing pituitary pathology in patients with Cushing’s disease. J Clin Endocrinol Metab (Baltimore) 83:2291–5, 1998.
Jastania RA, Alsaad KO, Al Shraim M, Kovacs K, Asa SL. Double adenomas of the pituitary: transcription factors pit-1, t-pit, and sf-1 identify cytogenesis and differentiation. Endocr Pathol 16:187–94, 2005.
Shintani Y, Yoshimoto K, Horie H, et al. Two different pituitary adenomas in a patient with multiple endocrine neoplasia type 1 associated with growth hormone-releasing hormone-producing pancreatic tumor: clinical and genetic features. Endocr J 42:331–40, 1995.
Kannuki S, Matsumoto K, Sano T, et al. Double pituitary adenoma–two case reports. Neurol Med Chir (Tokyo) 36:818–21, 1996.
Coons SW, Estrada SI, Gamez R, White WL. Cytokeratin CK7 and CK20 expression in pituitary adenomas. Endocr Pathol 16(3):201–10, 2005.
Felix IA, Horvath E, Kovacs K. Massive Crooke’s hyalinization in corticotroph cell adenomas of the human pituitary. A histological, immunocytological and electron microscopic study of three cases. Acta Neurochir (Wien) 58:235–43, 1981.
Horvath E, Kovacs K, Josse R. Pituitary corticotroph cell adenoma with marked abundance of microfilaments. Ultrastruct Pathol (New York) 5:249–55, 1983.
Franscella S, Favod-Coune C-A, Pizzolato G, et al. Pituitary corticotroph adenoma with Crooke’s hyalinization. Endocr Pathol 2:111–6, 1991.
George DH, Scheithauer BW, Kovacs K, et al. Crooke’s cell adenoma of the pituitary: an aggressive variant of corticotroph adenoma. Am J Surg Pathol 27:1330–6, 2003.
Chandrasekharappa SC, Guru SC, Manickam P, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276:404–7, 1997.
Asa SL, Singer W, Kovacs K, et al. Pancreatic endocrine tumour producing growth hormone-releasing hormone associated with multiple endocrine neoplasia type I syndrome. Acta Endocrinol (Copenhagen) 115:331–7, 1987.
Ezzat S, Asa SL. The multiple endocrine neoplasia syndromes. In: Kovacs K, Asa SL, editors. Functional endocrine pathology. Boston: Blackwell Science; pp. 952–66, 1998.
Brandi ML, Aurbach GD, Fitzpatrick LA, et al. Parathyroid mitogenic activity in plasma from patients with familial multiple endocrine neoplasia type 1. N Engl J Med 314:1287–93, 1986.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Al Brahim, N.Y.Y., Rambaldini, G., Ezzat, S. et al. Complex Endocrinopathies in MEN-1: Diagnostic Dilemmas in Endocrine Oncology. Endocr Pathol 18, 37–41 (2007). https://doi.org/10.1007/s12022-007-0008-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12022-007-0008-6